Clinically Important Drug-Drug Interactions and Clinical Decision Support On Demand Webinar
Release Date: June 11, 2013
Expiration Date: June 12, 2015
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity provides 1.0 hour (0.1 CEU) of continuing pharmacy education credit. (ACPE Activity Number: 0204-0000-13-002 H04-P)
Methods and Format
This is an online activity consist audio with the slides presentations, plus discussions, questions, and answers. Participants must participate in the entire activity and complete the online evaluation to receive continuing education credit. Follow the online prompts to claim and print your statement of credit immediately. This activity is provided free of charge.
Target Audience
This continuing pharmacy education activity is beneficial for pharmacists; who are struggling with Drug-Drug Interactions. Members needs assessment surveys indicate that this area is a major area of concern and problems. DDI is also a feature of “Meaningful Use” of the EHR, which is a federal requirement for CMS reimbursement for patient care. MU is requiring many hospitals to implement EHRs with DDI, which may or may not be optimized. The speakers will provide their insight on best use of DDI alerts in clinical decision support.
Activity Content
Injury due to a known DDI is a preventable adverse drug event and constitutes a serious medication error. Evidence suggests that hundreds of millions of interacting drugs are co-prescribed and consumed each year, ultimately exposing millions of patients to these known hazards.
This activity is intended for all pharmacists with an interest in drug-drug interactions, but specifically pharmacists with the responsibility to optimize computerized provider order entry (CPOE) and electronic prescribing (e-Rx) systems' clinical decision support (CDS). Those pharmacists charged with optimizing these systems to meet federal regulations ("Meaningful Use" (MU) of the Electronic Health Record (EHR)) will benefit from the concepts presented.
Learning Objectives
After participating in this knowledge-based CPE activity, participants should be able to:
- Describe basic mechanism of drug-drug interactions;
- Identify issues in determining which drug interactions are clinically important; and
- Discuss initiatives to identify a set of clinically important drug-drug interactions to incorporate into clinical decision support
Faculty
Daniel C. Malone, RPh, PhD, FAMCP, Professor, College of Pharmacy, University of Arizona, Tucson
Daniel C. Malone, RPh, PhD, is a professor at the College of Pharmacy and associate professor in Mel and Enid Zuckerman College of Public Health at the University of Arizona. He received a bachelor of science degree in pharmacy from the University of Colorado (magna cum laude) in 1987. Dr. Malone received a MS degree in 1990 and PhD degree in 1993 from The University of Texas. He completed an Agency for Healthcare Research and Quality (AHRQ) postdoctoral fellowship at the Departments of Public Health and Community Medicine and Pharmacy at the University of Washington. Prior to joining the University of Arizona he was an assistant professor at the University of Colorado. Dr. Malone is current the principal investigator on an AHRQ-funded dissemination grant to pharmacy and therapeutic committees on comparative effectiveness research. His current research interests include: developing strategies to prevent drug-drug interactions; improving health care professionals, knowledge of statistical and research methods; and evaluating the economic value of medical technologies. Dr. Malone has over 100 peer-review research publications and has been successful in obtaining over $15 million in extramural support for his research endeavors. Dr. Malone has conducted numerous research projects and economic studies of pharmaceuticals and healthcare technologies and policy issues associated with the use of pharmaceuticals. Dr. Malone’s research projects have involved a number of organizations, including the Department of Veterans, Kaiser Permanente, the state of Arizona’s Medicaid program, various managed care organizations and affiliated providers, and hospital systems.
Lisa Hines, PharmD, is a Clinical Research Pharmacist for the Center for Health Outcomes and PharmacoEconomic Research at the University Of Arizona College Of Pharmacy. She received her BS in Pharmacy from the University of Washington and her PharmD from The Ohio State University. Following completion of a pharmacy practice residency at The Ohio State University Medical Center, she was a clinical pharmacist for Grant/Riverside Medical Center and Grant Family Practice in Columbus, Ohio. After moving to Arizona, Dr. Hines was an Assistant Professor at Midwestern University – College of Pharmacy Glendale with a clinical practice site in family medicine. She also spent seven years in the pharmacy benefit management industry as a clinical pharmacist. In her current role at the University of Arizona, Dr. Hines served an investigator for the Arizona Center for Education and Research on Therapeutics and participated in various research projects focusing on drug-drug interactions. She also served as an investigator for a drug-drug interaction conference for which a group of key experts was assembled to summarize challenges and opportunities related to the generation, evaluation, and translation of drug interaction evidence for health information technology. Over the past five years, Dr Hines has published several articles, served on expert panels, and developed and conducted numerous lectures and educational programs related to drug-drug interactions.
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.
The faculty, planners, and ASHP Staff reports no relevant financial relationships exist pertinent to this activity.
Activity is planned and coordinated by ASHP Section of Pharmacy Informatics and Technology